FDA Amends Advisory Committee Meeting Details For Capricor Biologics Application
July 25, 2026
July 25, 2026
WASHINGTON, July 25 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued a notices document amending a prior notice regarding the Cellular, Tissue, and Gene Therapies Advisory Committee meeting for Capricor, Inc., San Diego, California's, biologics license application for deramiocel.
The meeting will occur on July 29, 2026, from 9:30 a.m. to 4:50 p.m. Eastern Time at the FDA White Oak Campus in Silver Spring, Maryland, with public ora . . .
The meeting will occur on July 29, 2026, from 9:30 a.m. to 4:50 p.m. Eastern Time at the FDA White Oak Campus in Silver Spring, Maryland, with public ora . . .